Changes to our website — to find out why access to some data now requires a login,
click here
The Open Database Of The Corporate World
Search
Companies
Officers
Log in/Sign up
PERCEIVE, INC.
Company Number
2015092800335
Status
Please log in to see this data
Incorporation Date
Please log in to see this data
Dissolution Date
Please log in to see this data
Company Type
Domestic For-Profit Corporation
Jurisdiction
Indiana (US)
Inactive Directors / Officers
5 officers available, please log in to see this data
Registry Page
Please log in for link to primary source
Recent filings for PERCEIVE, INC.
28 Jun 2022
Articles of Dissolution
31 May 2022
Resignation of Registered Agent
12 Jul 2021
Business Entity Report
25 Sep 2019
Business Entity Report
24 Jul 2019
Articles of Amendment
22 Mar 2019
Change of Officer
11 Jan 2019
Change of Principal Address
5 Dec 2018
Change of Officer
see all filings
Source
Indiana Secretary of State
,
https://inbiz.in.gov/Inbiz/BulkDataSe...
,
2 Mar 2023
Company Addresses
Head Office Address
9059 Technology Lane, Fishers, IN, 46038
Latest Events
2022-05-01 - 2022-06-30
Removal of officer Everett Berry, president
2022-05-01 - 2022-06-30
Removal of officer Everett Berry, secretary
2022-07-01 - 2022-09-30
Change of status from 'Voluntarily Dissolved (Name Protected)' to 'Voluntarily Dissolved'
See all events
Corporate Grouping
User Contributed
None known.
Add one now?
See all corporate groupings
Similarly named companies
Found 21.
Showing first 10
PERCEIVE, INC.
(California (US))
PERCEIVE NOW, INC.
(Delaware (US))
nonprofit
PERCEIVE Ministries Inc
(Pennsylvania (US))
PERCEIVE BIOTHERAPEUTICS, INC.
(Utah (US))
VoiceTrust eServices Canada Inc.
(Canada)
nonprofit
WE PERCEIVE, INC.
(Arkansas (US))
branch
PERCEIVE BIOTHERAPEUTICS, INC.
(California (US))
branch
PERCEIVE NOW, INC.
(Ohio (US))
branch
VoiceTrust eServices Canada Inc.
(Quebec (Canada))
branch
Perceive Biotherapeutics, Inc.
(Idaho (US))
Trademark registrations
Mark Text
Image
Register
NICE classifications
Registration Date
Expiry Date
VISITORX
United States Patent and Trademark Office
42
2020-08-25
details